日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial

新辅助帕博西尼联合内分泌治疗与化疗治疗ER+/HER2-乳腺癌：一项随机II期试验

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-71452-6
Matikas, Alexios; Tzoras, Evangelos; Sarafidis, Michail; Sifakis, Emmanouil G; Bjöhle, Judith; Barnekow, Elin; Margolin, Sara; Isaksson-Friman, Erika; Kessler, Luisa Edman; Zouzos, Athanasios; Johansson, Hemming; Hellström, Mats; Agartz, Susanne; Grybäck, Per; Salgkamis, Dimitrios; Zerdes, Ioannis; Wang, Kang; Hartman, Johan; Acs, Balazs; Sun, Wenwen; Boyaci, Ceren; Villacampa, Guillermo; Pascual, Tomas; Gavila, Joaquin; Prat, Aleix; Perou, Charles; Brandberg, Yvonne; Bergh, Jonas; Hatschek, Thomas; Foukakis, Theodoros
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Progression-free survival 2 (PFS2) as a surrogate endpoint for overall survival (OS) in breast cancer randomized controlled clinical trials

在乳腺癌随机对照临床试验中，无进展生存期2 (PFS2) 作为总生存期 (OS) 的替代终点

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2026.106062
Filis, P; Filis, N; Foukakis, T; Matikas, A
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Prevalence and prognosis of patients with breast cancer eligible for adjuvant abemaciclib or ribociclib: a nationwide population-based study

符合辅助阿贝西利或瑞博西尼治疗条件的乳腺癌患者的患病率和预后：一项全国性人群研究

期刊:Lancet Regional Health-Europe
影响因子:13
doi:10.1016/j.lanepe.2025.101471
Liu, Xingrong; Binicy, Behnaz; Acs, Balazs; Eriksson Bergman, Louise; Loibl, Sibylle; Gnant, Michael; Untch, Michael; Valachis, Antonios; Bergh, Jonas; Hartman, Johan; Foukakis, Theodoros; Matikas, Alexios
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Adherence to adjuvant endocrine therapy including GnRH-analogues and survival: a population-based cohort study

接受包括GnRH类似物在内的辅助内分泌治疗的依从性与生存率：一项基于人群的队列研究

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103493
Eriksson Bergman, Louise; Matikas, Alexios; Liu, Xingrong; Foukakis, Theodoros
发表日期：2025
文献求助 收藏

Optimization of guidelines for Risk Of Recurrence/Prosigna testing using a machine learning model: a Swedish multicenter study

利用机器学习模型优化复发风险/Prosigna检测指南：一项瑞典多中心研究

期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2025.104489
Kjällquist, Una; Tsiknakis, Nikos; Acs, Balazs; Margolin, Sara; Kessler, Luisa Edman; Levy, Scarlett; Ekholm, Maria; Lundgren, Christine; Olsson, Erik; Lindman, Henrik; Valachis, Antonios; Hartman, Johan; Foukakis, Theodoros; Matikas, Alexios
发表日期：2025
文献求助 收藏

Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial

基于机器学习的肿瘤免疫微环境空间特征分析在 EORTC 10994/BIG 1-00 早期乳腺癌试验中的应用

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-025-00730-1
Zerdes, Ioannis; Matikas, Alexios; Mezheyeuski, Artur; Manikis, Georgios; Acs, Balazs; Johansson, Hemming; Boyaci, Ceren; Boman, Caroline; Poncet, Coralie; Ignatiadis, Michail; Bai, Yalai; Rimm, David L; Cameron, David; Bonnefoi, Hervé; Bergh, Jonas; MacGrogan, Gaetan; Foukakis, Theodoros
肿瘤
肿瘤免疫
乳腺癌
BIG
免疫/内分泌
发表日期：2025
文献求助 收藏

Comprehensive genome profiling for treatment decisions in patients with metastatic tumors: real-world evidence meta-analysis and registry data implementation

针对转移性肿瘤患者的治疗决策，进行全面的基因组分析：真实世界证据荟萃分析和注册数据应用

期刊:Jnci-Journal of the National Cancer Institute
影响因子:7.2
doi:10.1093/jnci/djaf015
Zerdes, Ioannis; Filis, Panagiotis; Fountoukidis, Georgios; El-Naggar, Ali Inan; Kalofonou, Foteini; D'Alessio, Antonio; Pouptsis, Athanasios; Foukakis, Theodoros; Pentheroudakis, George; Ahlgren, Johan; Smith, Daniel; Valachis, Antonios
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study

高危早期三阴性乳腺癌患者新辅助帕博利珠单抗联合化疗疗效的分子决定因素：一项开放标签、多队列 1b 期 KEYNOTE-173 研究的探索性分析

期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-024-01946-y
Dent, Rebecca; Cortés, Javier; Park, Yeon Hee; Muñoz-Couselo, Eva; Kim, Sung-Bae; Sohn, Joohyuk; Im, Seock-Ah; Holgado, Esther; Foukakis, Theodoros; Kümmel, Sherko; Yearley, Jennifer; Wang, Anran; Nebozhyn, Michael; Huang, Lingkang; Cristescu, Razvan; Jelinic, Petar; Karantza, Vassiliki; Schmid, Peter
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Pathological response to pembrolizumab-based neoadjuvant therapy in ER-low vs. ER-zero breast cancer: a Swedish population-based cohort study

瑞典一项基于人群的队列研究：基于帕博利珠单抗的新辅助治疗在ER低表达乳腺癌和ER零表达乳腺癌中的病理反应

期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-025-02179-3
Steen, Sanna; Karlsson, Emelie; Björnheden, Ida; Rask, Gunilla; Thurfjell, Viktoria; Nobin, Hampus; Kolodziej, Blanka; Bodén, Anna; Bauer, Annette; Einefors, Rickard; Nilsson, Per; Zerdes, Ioannis; Papakonstantinou, Andri; Foukakis, Theodoros; Fredriksson, Irma; Rantalainen, Mattias; Colón-Cervantes, Eugenia; Kovács, Anikó; Acs, Balazs; Hartman, Johan
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Prognostic and predictive implications of sterile alpha motif and HD domain-containing protein 1 (SAMHD1) expression in breast cancer.

无菌α基序和HD结构域蛋白1（SAMHD1）表达在乳腺癌中的预后和预测意义

期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.35319
Kouvaraki Maria, Zerdes Ioannis, Sifakis Emmanouil G, Sarafidis Michail, Matikas Alexios, Tzoras Evangelos, Kjällquist Una, Stathopoulou Konstantina, Lövrot John, Alkodsi Amjad, Hartman Johan, Sotiriou Christos, Richard Francois, Hatschek Thomas, Herold Nikolas, Bergh Jonas, Rassidakis George Z, Foukakis Theodoros
肿瘤
乳腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏